Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2010 TO 2019]"
publishDate:"[2016 TO 2016]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=publishDate%3A%22%5B2016+TO+2016%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=publishDate%3A%22%5B2016+TO+2016%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=publishDate%3A%22%5B2016+TO+2016%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (1.648)
1
A MULTICENTER, PHASE III, OPEN-LABEL, RANDOMIZED STUDY IN RELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TO EVALUATE THE BENEFIT OF GDC-0199 (ABT-199) PLUS RITUXIMAB COMPARED WITH BENDAMUSTINE PLUS RITUXIMAB : A MULTICENTER, PHASE III, OPEN-LABEL, RANDOMIZED STUDY INRELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TO EVALUATE THE BENEFIT OF GDC-0199 (ABT-199)PLUS RITUXIMAB COMPARED WITH BENDAMUSTINE PLUS RITUXIMAB
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
2
A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic EMICIZUMAB versus No Prophylaxis in Hemophilia A Patients with Inhibitors : A RANDOMIZED, MULTICENTER, OPEN-LABEL,PHASE III CLINICAL TRIAL TO EVALUATE THEEFFICACY, SAFETY, AND PHARMACOKINETICSOF PROPHYLACTIC EMICIZUMAB VERSUS NOPROPHYLAXIS IN HEMOPHILIA A PATIENTS WITHINHIBITORS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
3
A MULTICENTER, PHASE III, OPEN-LABEL, RANDOMIZED STUDY IN RELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TO EVALUATE THE BENEFIT OF GDC-0199 (ABT-199) PLUS RITUXIMAB COMPARED WITH BENDAMUSTINE PLUS RITUXIMAB : A MULTICENTER, PHASE III, OPEN-LABEL, RANDOMIZED STUDY INRELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TO EVALUATE THE BENEFIT OF GDC-0199 (ABT-199)PLUS RITUXIMAB COMPARED WITH BENDAMUSTINE PLUS RITUXIMAB
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
4
A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic EMICIZUMAB versus No Prophylaxis in Hemophilia A Patients with Inhibitors : A RANDOMIZED, MULTICENTER, OPEN-LABEL,PHASE III CLINICAL TRIAL TO EVALUATE THEEFFICACY, SAFETY, AND PHARMACOKINETICSOF PROPHYLACTIC EMICIZUMAB VERSUS NOPROPHYLAXIS IN HEMOPHILIA A PATIENTS WITHINHIBITORS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
5
This study is to examine whether the combination of a low dose of a new drug Sirolimus in combination with a low dose of the standard anti-rejection medication Tacrolimus is safer and works equally well in patients after liver transplantation. : A multi-center randomized, open label, controlled study in primary liver transplantation comparing long term renal function and development of de novo malignancy in recipients treated with standard dose extended release tacrolimus alone and recipients treated with a combination of low dose extended-release tacrolimus and low dose sirolimus. - LOL-III
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
6
Visualizing beta cells in morbid obese patients with T2D before and after bariatric surgery(NL51980.091.15) : Visualizing beta cells in morbid obese patients with T2D before and after bariatric surgery(NL51980.091.15) - Visualizing beta cells before and after bariatric surgery
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
7
A Prospective Follow-Up Study of Children Aged 23 to 25 months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth : A Prospective Follow-Up Study of Children Aged 23 to 25 months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
8
A rollover study for patients who have participated in a Novartis-sponsored ribociclib (LEE011) study and are continuing to benefit from ribociclib alone or in combination with other agents : An open-label, multi-center rollover protocol for patients who have participated in a Novartis-sponsored ribociclib (LEE011) study and are continuing to benefit from ribociclib as single agent or in combination with other investigational treatments
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
9
A study evaluating venetoclax (ABT-199) in subjects with Chronic Lymphocytic Leukemia (CLL) whose cancer has come back or who had no response to previous cancer treatments including subjects who may be missing part of their chromosome 17 identified as 17p deletion, or TP53 gene mutation; or subjects who previously received treatment with B-cell receptor inhibitors. : Open-Label, Single Arm, Phase 3B, Multi-Center Study Evaluating the Efficacy of Venetoclax (ABT 199) in Relapsed/Refractory Subjects with Chronic Lymphocytic Leukemia (CLL) including those with the 17p Deletion or TP53 Mutation OR Those Who Have Received Prior Treatment with a B-Cell Receptor Inhibitor
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
10
Rituximab plus lenalidomide or rituximab monotherapy for untreated patients with follicular lymphoma in need of therapy. : Rituximab plus lenalidomide or rituximab monotherapy for untreated patients with follicular lymphoma in need of therapy. A randomized, open-label, multicentre phase II trial.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[165]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2010-2019
Filter aufheben
Erscheinungsjahr: 2016-2016
Medienart
1.648
Aufsätze
1.648
E-Artikel
1.648
E-Ressourcen
Zeitschriftentitel
1.648
WHO International Clinical Trials Registry Plat...
Thema
1.648
610
1.648
Recruitment Status: Authorised-recruitment may ...
1.648
Study Type: Interventional
398
Phase: Phase 3
328
Phase: Phase 2
312
Phase: Phase 4
68
Phase: Phase 1
12
Medical Condition: Moderately to Severely Activ...
8
Medical Condition: Locally Advanced or Metastat...
6
Medical Condition: Ischemic heart disease and h...
6
Medical Condition: Locally advanced or metastat...
6
Medical Condition: Metastatic Castration-Resist...
6
Medical Condition: Moderate to Severe Plaque Ps...
6
Medical Condition: platinum sensitive serous ov...
4
Medical Condition: Advanced Kidney Cancer MedDR...
4
Medical Condition: Asthma;Therapeutic area: Dis...
4
Medical Condition: Chronic Lymphocytic Leukemia...
4
Medical Condition: Endometriosis MedDRA version...
4
Medical Condition: Erosive Esophagitis in paedi...
4
Medical Condition: Esophageal Carcinoma MedDRA ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2016-2016
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.570
Englisch
46
Unbestimmt
16
Französisch
6
Dänisch
4
Finnisch
2
Niederländisch
2
Italienisch
2
Norwegisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...